In This Issue: Drug Topics July/August 2024

Researchers analyzed the outcomes of positive airway pressure therapy for Medicare beneficiaries with obstructive sleep apnea.

Drug Topics discussed independent pharmacy advocacy and PBM reform on the federal level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.

Researchers conducted a meta-analysis detailing previous patient outcomes in response to visual art therapy interventions.

Jeremy Cundiff, PharmD, co-owner of Professional Pharmacy Group, joined Drug Topics to discuss Return Solutions and the company’s Rx Returns process.

Check out important updates from the FDA for the week of August 9.

Findings could inform future clinical practices on the treatment of DED for the more than 400 million people worldwide with the condition.